Navigation Links
International Substance Detection Firm IDenta To Release New Lead Test Kit - Rash Of Toy Incidents Leads Company To Enter New Marketplace
Date:12/3/2007

JERUSALEM, Israel, December 3 /PRNewswire-FirstCall/ -- IDenta Corp. (OTC: IDTA.PK - News) announced today that it is in the final stages of releasing a new test kit that will detect the presence of lead in a wide variety of products including children's toys. The recent outbreak of lead contamination in products produced in China prompted the company to develop the new product line. As yet unnamed, the new IDenta lead detector will be targeted for sale to both the consumer marketplace as well as companies with products produced overseas.

"Lead contamination has unfortunately re-emerged as a serious threat to consumers world-wide, especially innocent children," declared Yaacov Shoham IDTA CEO. "There are hundreds of U.S. companies using overseas contract manufacturing that now must implement new detection procedures to protect them from product liability. We are developing this product to help these companies and the thousands of consumers that are concerned about the safety of overseas produced products, like toys, that are not up to U.S. product safety codes and standards."

The new lead test kit will be composed of two ampoules filled with special testing liquids and a special testing paper. It will be very easy to use for consumers as well as for industrial and commercial uses. The new product will meet the same stringent product standards of IDenta products and is expected to yield no false positives or false negatives. Each kit will contain 10 tests which will have an extended shelf life. Pricing for each kit is expected to be less than $15.00

U.S. companies interested in selling the new product or interested in receiving samples of the new IDenta Lead tester should email Mr. Shoham directly at fpi@drugsdetector.com

About Lead Poisoning

Lead is a highly toxic substance, exposure to which can produce a wide range of adverse health effects. Both adults and children can suffer from the effects of lead poisoning but young children under the age of six are especially vulnerable to lead's harmful health effects, because their brains and central nervous system are still being formed. Low levels of exposure to lead can result in reduced IQ, learning disabilities, attention deficit disorders, behavioral problems, stunted growth, impaired hearing, and kidney damage. At high levels of exposure, a child may become mentally retarded, fall into a coma, and even die from lead poisoning. Lead poisoning has also been associated with juvenile delinquency and criminal behavior. Exposure to lead is estimated by measuring levels of lead in the blood (in micrograms of lead per deciliter of blood). The US Centers for Disease Control and Prevention (CDC) has set a "level of concern" for children at 10 micrograms per deciliter.

About IDenta

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civilian markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at http://www.IDenta.biz.

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning

IDenta's products internationally contact:

Yaacov Shoham, IDenta Corp. CEO

Tel: +972-52-6554487

fpi@drugsdetector.com

For Investor Relations in the US contact:

Randy Jacobs, Corporate Spokesman

IDentaNews@sitcomllc.com

1-800-316-9437


'/>"/>
SOURCE IDenta Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank
3. International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers
4. Arrow International Files and Mails Definitive Proxy Materials
5. Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software
6. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
7. Viragen International to Reverse Split Its Common Stock
8. Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products
9. Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products
10. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
11. Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... WEST LAFAYETTE, Indiana (PRWEB) , ... ... ... a division of Albany Molecular Research Inc. has further extended its industry ... sector. This service offers state-of-the-art cGMP techniques and methods for the ...
(Date:2/15/2017)... Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), today announced financial ... full year ended December 31, 2016. ... we continued to demonstrate strong growth in our ... said Mihael H. Polymeropoulos, M.D., Vanda,s President and ... 2017 milestones underscores Vanda,s commitment to bringing important ...
Breaking Biology Technology:
(Date:2/10/2017)... Research and Markets has announced the addition ... and Commercial Aspects" to their offering. ... Biomarkers play an ... for selection of treatment as well for monitoring the results. ... in modern medicine. Biochip/microarray technologies and next generation sequencing are ...
(Date:2/8/2017)... NEW YORK , Feb. 7, 2017 Report ... ... and should reach $11.4 billion by 2021, growing at a ... Report Includes - An overview of the global markets for ... from 2015, estimates for 2016, and projections of compound annual ...
(Date:2/7/2017)... Feb. 7, 2017 Zimmer Biomet Holdings, Inc. ... healthcare, will present at the LEERINK Partners 6th Annual ... Hotel on Wednesday, February 15, 2017 at 10 a.m. ... the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  ... conference via Zimmer Biomet,s Investor Relations website at ...
Breaking Biology News(10 mins):